Add IOBT to Watchlist?
  • Easy Tracking In The Watchlist

IOBT Performance

FAQ

What is the symbol for IO Biotech, Inc. Stock and on which exchange is it traded?
The symbol for IO Biotech, Inc. is IOBT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell IO Biotech, Inc. Stock?
IO Biotech, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy IO Biotech, Inc. Stock?
IO Biotech, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy IO Biotech, Inc. Stock.

What's the current price of IO Biotech, Inc. Stock?
As of the end of day on the Jun 17, 2026, the price of an IO Biotech, Inc. (IOBT) share was $0.0480.

What is the 52-week high and low for IO Biotech, Inc. Stock?
The 52-week high for IO Biotech, Inc. Stock is $2.79 and the 52-week low is $0.0060.

What is the market capitalization of IO Biotech, Inc. Stock?
As of the Jun 17, 2026, the market capitalization of IO Biotech, Inc. is 885.69K.
Click to get the best stock tips daily for free!
ABOUT IO BIOTECH, INC.
IO Biotech
IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 2 clinical trial to treat melanoma, as well as in phase 1 clinical trial to treat lung, head and ne...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.87% Jun 12
DHI
$146.71
3.93% Jun 10
PHM
$118.49
2.86% Jun 10
EAT
$140.46
13.06% Jun 05
TPR
$140.47
3.84% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE